Martijn Wilmer Ph.D.
Post doc
- Martijn Wilmer Ph.D.
- +31 24 36 10575
- m.wilmer@pharmtox.umcn.nl
Martijn Wilmer completed his PhD in Medical Sciences at the
department of Pediatrics at the Radboud University Nijmegen Medical
Centre in 2010. He investigated the pathogenesis of the inherited
disorder nephropathic cystinosis, for which he developed a human
renal proximal tubular cell line, ciPTEC. He used this cell line to
study drug-drug interactions as a postdoctoral researcher at the
Radboud University Nijmegen Medical Centre, department of
Pharmacology and Toxicology. In addition to his interests in the
regulation of renal drug transporters, pharmacokinetics and the
development of a biological kidney support device, he is exploring
the possibilities to commercialize his activities using the
patented ciPTEC in collaboration with the pharmaceutical industry.
In July 2011, he started on a collaboration project between the
departments of Pharmacology-Toxicology, Physiomics and Pediatrics
to improve kidney repair through cell fate changes and
reprogramming, funded by the Netherlands Initiative for
Regenerative Medicine.
